Scientists in the United States are carrying out research using embryonic stem cells in a bid to offer help for people suffering from type 1 diabetes .
The team, from a company based in San Diego called ViaCyte Inc. have developed a new kind of medical implant that assists diabetic patients in managing their blood sugar levels . The method consists of a type of envelope filled with embryonic stem cells and implanted under the skin, so that the cells involved become pancreatic cells .
People who have type 1 diabetes usually need insulin injections or an insulin pump to control their blood sugar, although this approach can be inconvenient and difficult to stick to. Eugene Brando, a director at ViaCyte, has claimed that the device has already been used to successfully treat diabetes in mice. He commented on the research, “We’re essentially creating a replacement pancreas .”
However, Vivian Fonsecan, president-elect for medicine and science at the American Diabetes Associatio, also said “What people want is a single, one-time cure. I don’t see that happening in the foreseeable future”, although he argued that stem cell research could be a step in the right direction.
The company plans to start human trials by 2013, funded by the California Institute of Regenerative Medicine, the state’s stem cell funding agency.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…